Aurora Cannabis gains 21% as its medical segment fuels revenue and margin growth, even as recreational sales drag.
U.S.-listed shares of Canopy Growth and Tilray Brands both jumped nearly 20% before the bell, while Cronos Group added 9.5% and Aurora Cannabis gained 13.7%, respectively. The AdvisorShares Pure U.S.
Zacks Investment Research on MSN
Aurora Cannabis (ACB) Soars 6.2%: Is Further Upside Left in the Stock?
Aurora Cannabis Inc. (ACB) shares rallied 6.2% in the last trading session to close at $6.17. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Aurora Cannabis Inc. closed 25.62% below its 52-week high of $6.91, which the company reached on February 10th.
Jasmine Crockett undisclosed stocks and marijuana business ties raise ethics concerns about her financial transparency and ...
Aurora Cannabis Inc. closed 21.85% short of its 52-week high of $6.91, which the company achieved on February 10th.
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis ...
Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.
EDMONTON, ALBERTA, Aug. 12, 2025 /PRNewswire/ - Aurora Cannabis Inc. (ACB), the Canadian-based leading global medical cannabis company, announces the launch of Whistler Cannabis Co. in Australia. As ...
EDMONTON, AB, Sept. 9, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announced the launch of the English-language ...
Marijuana delivery may soon be arriving in Aurora, Colorado. The city council there on Monday night agreed to advance a proposal that would permit pot delivery during certain times for individuals who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results